Steven Madonick

1.9k total citations
15 papers, 1.5k citations indexed

About

Steven Madonick is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, Steven Madonick has authored 15 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Pharmacology and 7 papers in Psychiatry and Mental health. Recurrent topics in Steven Madonick's work include Neurotransmitter Receptor Influence on Behavior (8 papers), Schizophrenia research and treatment (6 papers) and Tryptophan and brain disorders (4 papers). Steven Madonick is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (8 papers), Schizophrenia research and treatment (6 papers) and Tryptophan and brain disorders (4 papers). Steven Madonick collaborates with scholars based in United States, South Korea and United Kingdom. Steven Madonick's co-authors include John H. Krystal, Walid Abi‐Saab, Ralitza Gueorguieva, Thomas B. Cooper, Deepak Cyril D’Souza, Ayşenil Belger, Gabriel Braley, Kimberlee Forselius-Bielen, Deepak Cyril D’Souza and Ismene L. Petrakis and has published in prestigious journals such as Biological Psychiatry, Neuropsychopharmacology and Psychopharmacology.

In The Last Decade

Steven Madonick

15 papers receiving 1.4k citations

Peers

Steven Madonick

CMN

PHARM

PMH

Mitsuhiro Kamata Japan

Deepak Cyril D’Souza United States

Elinore McCance United States

David Pickar United States

Suham Kassir United States

Herbert Y. Meltzer United States

Tai‐Jui Chen Taiwan

Enrico Lattuada Italy

Christopher D. Verrico United States

Paul B. Hicks United States

Mitsuhiro Kamata Japan

Steven Madonick

514 ×0.7

CMN

441 ×0.7

PHARM

430 ×0.8

PMH

176 ×0.5

238 ×0.9

Citations per year, relative to Steven Madonick Steven Madonick (= 1×) peers Mitsuhiro Kamata

Countries citing papers authored by Steven Madonick

Since Specialization

Citations

This map shows the geographic impact of Steven Madonick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Madonick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Madonick more than expected).

Fields of papers citing papers by Steven Madonick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Madonick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Madonick. The network helps show where Steven Madonick may publish in the future.

Co-authorship network of co-authors of Steven Madonick

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Madonick. A scholar is included among the top collaborators of Steven Madonick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Madonick. Steven Madonick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vaughan, David N., et al.. (2014). Review of international early psychosis programmes and a model to overcome unique challenges to the treatment of early psychosis in the United States. Early Intervention in Psychiatry. 9(1). 1–11. 17 indexed citations

D’Souza, Deepak Cyril, Roberto Gil, Steven Madonick, et al.. (2006). Enhanced Sensitivity to the Euphoric Effects of Alcohol in Schizophrenia. Neuropsychopharmacology. 31(12). 2767–2775. 39 indexed citations

Krystal, John H., Steven Madonick, Edward Perry, et al.. (2006). Potentiation of Low Dose Ketamine Effects by Naltrexone: Potential Implications for the Pharmacotherapy of Alcoholism. Neuropsychopharmacology. 31(8). 1793–1800. 43 indexed citations

D’Souza, Deepak Cyril, Walid Abi‐Saab, Steven Madonick, et al.. (2005). Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction. Biological Psychiatry. 57(6). 594–608. 452 indexed citations

Cho, Hyun Sang, Deepak Cyril D’Souza, Ralitza Gueorguieva, et al.. (2005). Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine. Psychopharmacology. 179(1). 136–143. 33 indexed citations

Krystal, John H., Edward Perry, Ralitza Gueorguieva, et al.. (2005). Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine. Archives of General Psychiatry. 62(9). 985–985. 258 indexed citations

Woods, Scott W., Michelle C. Sullivan, Esperanza Díaz, et al.. (2003). Best Practices: Racial and Ethnic Effects on Antipsychotic Prescribing Practices in a Community Mental Health Center. Psychiatric Services. 54(2). 177–179. 15 indexed citations

Duncan, Erica, Sándor Miklós Szilágyi, Toby R. Efferen, et al.. (2003). Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia. Psychopharmacology. 167(1). 63–71. 56 indexed citations

Duncan, Erica, Steven Madonick, Subhajit Chakravorty, et al.. (2001). Effects of smoking on acoustic startle and prepulse inhibition in humans. Psychopharmacology. 156(2-3). 266–272. 85 indexed citations

10.

Bowers, Malcolm B., Nashaat N. Boutros, Deepak Cyril D’Souza, & Steven Madonick. (2001). Substance Abuse as a Risk Factor for Schizophrenia and Related Disorders. International Journal of Mental Health. 30(1). 33–57. 12 indexed citations

11.

Duncan, Erica, Elsa J. Bartlett, Steven Madonick, et al.. (2000). Impaired prepulse inhibition of acoustic startle in schizophrenia. Biological Psychiatry. 47(7). 662–669. 197 indexed citations

12.

D’Souza, Deepak Cyril, et al.. (2000). Cannabinoids & psychosis: Evidence from studies with I.V THC in schizophrenic patients and controls. Schizophrenia Research. 41(1). 33–33. 15 indexed citations

13.

Krystal, John H., et al.. (2000). Ketamine and amphetamine interactions in healthy humans: Further insights into glutamate-dopamine interactions. Schizophrenia Research. 41(1). 235–236. 1 indexed citations

14.

Krystal, John H., Deepak Cyril D’Souza, Steven Madonick, & Ismene L. Petrakis. (1999). Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophrenia Research. 35. S35–S49. 72 indexed citations

15.

Krystal, John H., Cyril D’Souza, Ismene L. Petrakis, et al.. (1999). NMDA Agonists and Antagonists as Probes of Glutamatergic Dysfunction and Pharmacotherapies in Neuropsychiatric Disorders. Harvard Review of Psychiatry. 7(3). 125–143. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact